UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation) |
(Commission File Number) | (I.R.S. Employer Identification Number) |
(Address of principal executive offices)
(
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.)
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
| The |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.07. Submission of Matters to a Vote of Security Holders.
On December 30, 2025, Avalon GloboCare Corp. (the “Company”) held a virtual annual meeting of stockholders to vote on the following matters:
1. Election of Directors
Stockholders voted to elect the six nominees for director named below to the Company’s Board of Directors, each to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified, in accordance with the voting results below:
| Nominee Name | For | Withhold | Broker Non-Votes | |||
| Wenzhao “Daniel” Lu | 792,744 | 14,638 | 848,349 | |||
| Lourdes Felix | 771,591 | 35,791 | 848,349 | |||
| Steven A. Sanders | 767,042 | 40,340 | 848,349 | |||
| William B. Stilley, III | 744,869 | 62,513 | 848,349 | |||
| Wilbert J. Tauzin II | 791,450 | 15,932 | 848,349 | |||
| Tevi Troy | 768,039 | 39,343 | 848,349 |
2. Ratification of Independent Registered Public Accounting Firm
Stockholders voted to approve ratification of the appointment of M&K CPAS, PLLC as the Company’s independent registered public accounting firm for the Company’s fiscal year ending December 31, 2025, in accordance with the voting results below:
| For | Against | Abstain | Broker Non-Votes | |||
| 1,641,580 | 3,555 | 10,596 | - |
1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| AVALON GLOBOCARE CORP. | ||
| Dated: January 5, 2026 | By: | /s/ Luisa Ingargiola |
| Name: | Luisa Ingargiola | |
| Title: | Chief Financial Officer | |
2